Major tobacco companies pay almost no corporation tax despite massive profits

February 06, 2019

The world's four major tobacco companies - two of which have HQs in the UK - are paying minimal UK corporation tax despite enormous reported profits, according to findings from new research published in the Journal of Public Health.

The study, authored by researchers at the University of Bath, suggests that the UK needs far better reporting standards for corporation tax in order to hold tobacco companies to account in meeting the enormous public health costs caused by their deadly product.

They call for extension of the bank focused corporation tax surcharge to cover tobacco companies and also for mandated country by country reporting on tobacco sales and profits. The bank focused corporation tax surcharge currently adds an additional 8% tax on the profits of banks.

Previous work from the same authors shows that tobacco companies enjoy inordinate profits on their highly addictive product. Profits have increased over recent years despite declining sales because regular price increases on cigarettes have outpaced people's ability to give up smoking.

For the current study, which set out to identify profit earned and tax paid by the different tobacco companies operating in the UK, the team extracted profit and tax data from company annual financial statements covering 2009 to 2016.

Their work focused on the four big tobacco companies operating in the UK: Imperial Brands and British American Tobacco (BAT) (both headquartered in the UK); and the main UK subsidiaries of Philip Morris International (Philip Morris Limited) and Japan Tobacco International (Gallagher Ltd).

The findings reveal:

The reporting of Corporation Tax and company accounts in the UK is 'wholly inadequate':

-- From 2014, Imperial Brands were allowed to stop reporting UK-adjusted operating profits; BAT and PMI have never done so; and none of the four transnational tobacco companies (TTCs) reported profit before tax in the UK.

-- Companies have reorganised corporate structures to enable profits to be shifted overseas.

The major tobacco companies operating in the UK are not paying Corporation Tax at anything like the rate they should be:

-- In 2016, Imperial Brands, BAT, and Gallagher together made UK operating profits in excess of £1bn yet paid just £83.6m in corporation tax.

-- Over the last 7 years during which time Corporation Tax has varied between 20 - 28%, Imperial Tobacco paid, at most, an estimated effective rate of 13% and often much lower and BAT paid 'virtually no' corporation tax, including four consecutive years from 2011-14 where they paid nothing at all.

UK-based tobacco companies are paying significantly more in Corporation Tax overseas:

-- In 2016, Imperial Brands made £3.5bn in global adjusted operating profits, paying £467m in overseas profit taxation. On their estimated UK earnings for the same period of £937m it paid just £33m in UK corporation tax.

-- In 2016 BAT made £6.2bn in global operating profit before tax, paying £1.4bn in overseas profit taxation. BAT UK earnings could not be determined due to inadequate reporting, but it paid only £7m in UK corporation tax.

Lead author, Dr Rob Branston from the University of Bath School of Management said: "Taxes are the best weapon we have available to reduce the harms caused by smoking, both in terms of encouraging smokers to stop and in recouping the enormous costs to society. But despite the enormous profits these companies enjoy, levels of corporation tax paid are pitiful.

"The government must better hold these companies to account and an essential first step is the publication of accurate country by country information on sales and profits. We urge the government to consider an extension of the bank focused corporation tax surcharge to cover tobacco companies."

Co-author, Professor Anna Gilmore, Director of the Tobacco Control Research Group at the University of Bath and co-Director of STOP (Stopping Tobacco Organisations and Products), the new tobacco industry watchdog, added: "With the NHS under intense funding pressure, these findings need to be acted upon by the Treasury. It is unacceptable that tobacco companies, which are enormously profitable, are not paying for the harm they cause. Until they begin to do so, they remain incentivised to keep selling their uniquely deadly product."

According to recent government analysis the cost of smoking to the economy was £11bn a year to England alone in 2017. In that year, £9.5bn was generated in excise duty from tobacco products in the UK, leaving a deficit of at least £1.5bn, not met by current insufficient Corporation Taxes.

The authors acknowledge that the study is limited by the available public data on tobacco company profitability and tax liabilities/allowances, both globally and for the UK market in particular. The work was supported by a Cancer Research UK grant (C50816/A25745). The funder played no role in the study design, analysis and interpretation of data, writing, or the decision to submit this article for publication.

George Butterworth, Cancer Research UK's policy manager, said: "Preventable diseases caused by tobacco products cost the NHS billions each year. The tobacco industry is dodging its obligation to contribute to the UK tax system leaving the public to pay for clearing up the mess caused by its products. The government should impose a tobacco industry levy, considering a surcharge on corporation tax or other mechanisms, to help fund services to help smokers quit."
The Tobacco Control Research Group at Bath is a partner of Stopping Tobacco Organisations and Products (STOP). STOP is a new global tobacco industry watchdog whose mission is to expose tobacco industry strategies and tactics that undermine public health.

University of Bath

Related Tobacco Products Articles from Brightsurf:

LSU Health New Orleans review suggests HNB tobacco products may threaten health
A review of heat-not-burn (HNB) tobacco products from LSU Health New Orleans School of Medicine, reports an association with elevated blood pressure, increased heart rate, cell death, and circulatory dysfunction shown by early studies.

New nitrogen products are in the air
A nifty move with nitrogen has brought the world one step closer to creating a range of useful products -- from dyes to pharmaceuticals -- out of thin air.

Live Biotherapeutic products -- a new regulatory approach for the safety assessment of a specific category of biological medicinal products
These exist complex challenges when developing Live Biotherapeutic Products (LBPs).

BAT study examines how people use vapor and tobacco heating products
The way consumers use vapor and tobacco heating products (THPs) can affect the levels of harmful and potentially harmful constituents they are exposed to, and a new study has analysed how the use of these products compares with cigarette smoking.

A tale of two cities: Impact of reducing teens' access to flavored tobacco products
Restricting youth access to flavored tobacco products holds the promise of reducing their overall tobacco use, according to a new study in the American Journal of Preventive Medicine, published by Elsevier.

Study examines first use of flavored tobacco products
Associations between the first use of flavored tobacco products and subsequent use of those products were examined in this observational study based on nationally representative survey data of more than 38,400 youth and adults in the United States.

E-cigarettes, tobacco and cannabis products are littering high schools
High schools in the San Francisco Bay Area are being contaminated by plastics and toxic litter from e-cigarettes, cannabis products and combustible tobacco products such as cigarettes and cigarillos, a new study by researchers at UC San Francisco has found.

Oral health effects of tobacco products: Science and regulatory policy proceedings
AADR held the 'Oral Health Effects of Tobacco Products: Science and Regulatory Policy' meeting.

An unnatural way to make natural products
Researchers have developed an innovative new process for synthesizing isoprenoids, which are chemical compounds used in countless pharmaceutical and consumer products.

Tobacco and e-cig promotions spark teens' use of nicotine products, Stanford study finds
Owning items that promote e-cigarettes and other alternative tobacco products doubles the likelihood that a young person will try these products, a new study led by the Stanford University School of Medicine has found.

Read More: Tobacco Products News and Tobacco Products Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to